Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial

Detalles Bibliográficos
Autores principales: Ramasamy, Karthik, Iqbal, Gulnaz, Brouwer, Richard, Stalker, Victoria, Akhtar, Salma, Varghese, Sherin, Lindsay, Jindriska, Schey, Stephen, Drayson, Mark, Dunn, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708638/
https://www.ncbi.nlm.nih.gov/pubmed/36446771
http://dx.doi.org/10.1038/s41408-022-00758-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708638/
https://www.ncbi.nlm.nih.gov/pubmed/36446771
http://dx.doi.org/10.1038/s41408-022-00758-7

Ejemplares similares